Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00421057 · ClinicalTrials.gov registry record
Combined Strength Training and Functional Endurance Exercise Regimen on Cancer -Related Fatigue and Physical Performance
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 25
- Enrollment target
NCT00421057: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00421057 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00421057 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
Primary Objective: -Determine if a specific exercise regimen (combined strength training/functional endurance) reduces the level of fatigue among women with breast cancer while undergoing adjuvant or neoadjuvant chemotherapy treatment as compared to a control group. Secondary Objectives: * Determine if a specific exercise regimen (combined strength training/functional endurance) increases the overall ability to perform daily physical activities (ADLs) among women with breast cancer while undergoing adjuvant or neoadjuvant chemotherapy treatment as compared to a control group. * Determine if a specific exercise regimen (combined strength training/ functional endurance) increases mobility in women with breast cancer while undergoing adjuvant or neoadjuvant chemotherapy treatment as compared to a control group. * Determine if a specific exercise regimen (combined strength training/functional endurance) increases endurance in women with breast cancer while undergoing adjuvant or neoadjuvant chemotherapy as compared to a control group.
Interventions
- BEHAVIORAL Questionnaire
- BEHAVIORAL Combined Strength Training and Functional Endurance Exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2007-01 |
| Est. Completion | 2009-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00421057
The ClinicalTrials.gov registry entry for NCT00421057 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Questionnaire is the first listed.
NCT00421057 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00421057 about?
NCT00421057 is a clinical study titled "Combined Strength Training and Functional Endurance Exercise Regimen on Cancer -Related Fatigue and Physical Performance". Primary Objective: -Determine if a specific exercise regimen (combined strength training/functional endurance) reduces the level of fatigue among women with breast cancer while undergoing adjuvant or neoadjuvant chemotherapy treatment as compared to a control group. Secondary Objectives: * Determ...
What is the current status of trial NCT00421057?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2007-01. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00421057?
The interventions under investigation include: Questionnaire (BEHAVIORAL), Combined Strength Training and Functional Endurance Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT00421057?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.